All 2026 2025 2024 2023 2022 2021 2020 2019 2018 July 13, 2021 Certara Announces New Chief Human Resources Officer July 8, 2021 Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform June 23, 2021 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions June 14, 2021 Certara Appoints Dr. Carol Gallagher as New Independent Board Member May 20, 2021 Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference May 13, 2021 Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies May 6, 2021 Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance May 4, 2021 Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier April 30, 2021 Certara to Present at the BofA Securities 2021 Virtual Health Care Conference April 22, 2021 Certara to Report Preliminary First Quarter 2021 Financial Results on May 6, 2021
July 8, 2021 Certara Announces Update of BaseCase Software, the Company’s Value Communication Platform
June 23, 2021 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
May 20, 2021 Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
May 13, 2021 Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 4, 2021 Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
